Back to results
US 11,883,465 B2Granted
Method of treating Parkinson's disease with intranasal delivery of insulin and glutathione
AssigneeGateway Institute for Brain Research, LLC
InventorNancy Klimas
Life of this patent
Estimating the term…
Abstract
A method for treating Parkinson's disease where insulin and GSH may be administered intranasally. The GSH and insulin that is administered may be in varying doses at least once daily. The GSH and insulin may be administered sequentially and/or simultaneously and the medications may be administered for differing periods of time depending upon a patient's tolerance and response to the GSH and insulin. The GSH and the insulin may be administered for a certain period of time and/or indefinitely.
Claims4
A method for the treatment of Parkinson's disease, the method comprising:
- administering at least 200 milligrams (“mg”) of glutathione (“GSH”) intranasally at least once daily;
- and
- administering 20 international units (“IU”) of insulin bid and at least 100 mg of GSH intranasally at least twice daily.
Dependencies are inferred from the claim text.